These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 26530040
1. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study. Takahashi T, Sakakibara H, Morikawa Y, Miura M. Pediatr Rheumatol Online J; 2015 Nov 04; 13(1):44. PubMed ID: 26530040 [Abstract] [Full Text] [Related]
2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H. Postgrad Med; 2018 May 04; 130(4):442-447. PubMed ID: 29745742 [Abstract] [Full Text] [Related]
3. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease. Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y. Pediatr Cardiol; 2017 Feb 04; 38(2):375-380. PubMed ID: 27878631 [Abstract] [Full Text] [Related]
5. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F. Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400 [Abstract] [Full Text] [Related]
8. Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease. Yoshida M, Oana S, Masuda H, Ishiguro A, Kato H, Ito S, Kobayashi T, Abe J. Clin Pediatr (Phila); 2018 Feb 21; 57(2):189-192. PubMed ID: 28952328 [Abstract] [Full Text] [Related]
9. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Pediatrics; 2004 Dec 21; 114(6):e689-93. PubMed ID: 15545617 [Abstract] [Full Text] [Related]
10. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study. Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y. J Int Med Res; 2024 May 21; 52(5):3000605241252115. PubMed ID: 38713460 [Abstract] [Full Text] [Related]
11. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease. Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP. Kaohsiung J Med Sci; 2012 Jan 21; 28(1):23-9. PubMed ID: 22226058 [Abstract] [Full Text] [Related]
14. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease. Zhao CN, Du ZD, Gao LL. Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036 [Abstract] [Full Text] [Related]
16. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study. Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M. Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872 [Abstract] [Full Text] [Related]
18. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD. J Microbiol Immunol Infect; 2007 Oct 26; 40(5):395-400. PubMed ID: 17932598 [Abstract] [Full Text] [Related]
20. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better? Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P. Cardiovasc Ther; 2021 Oct 26; 2021():6660407. PubMed ID: 34239607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]